Associação entre excesso de peso e hábito de fumar, Santarém, PA, 2007

OBJETIVO: Estudar associação entre excesso de peso e hábito de fumar. METODOLOGIA: Estudo transversal desenvolvido por telefone numa amostra probabilística de adultos (Santarém /PA), em 2007. Variável desfecho foi excesso de peso, explanatória hábito de fumar e de confusão idade, escolaridade, união conjugal, estado nutricional prévio, abuso de bebidas alcoólicas, atividade física no lazer e padrão alimentar. Associação entre excesso de peso e demais variáveis foi investigada pelo teste do qui-quadrado e regressão de Poisson para o cálculo das razões de prevalência de excesso de peso conforme hábito de fumar, considerando-se três níveis de hierarquia: características sociodemográficas, estado nutricional prévio e padrão comportamental. RESULTADOS: Verificou-se 40,6% de excesso de peso e 16,4% de fumantes. As variáveis associadas ao excesso de peso foram: maior idade, menor escolaridade, união conjugal estável, excesso de peso aos 20 anos e hábito de não consumo de refrigerante para ambos os sexos; não ativo no lazer para homens e hábito de fumar (atual e passado) para mulheres. As razões de prevalência de excesso de peso não apresentaram associação com hábito de fumar para homens, porém para mulheres houve tendência de maior prevalência de excesso de peso para fumantes atuais, chegando a 2,56 vezes mais do que para nunca fumantes e ex-fumantes. CONCLUSÃO: Este estudo constatou que a prevalência de excesso de peso foi maior para mulheres fumantes, comparativamente às ex-fumantes e nunca fumantes. Para os homens não se observou nenhuma associação entre excesso de peso e tabagismo.

Evaluation of the Bond Strength Between a Composite Resin and Enamel Submitted to Bleaching Treatment and Etched with Er:YAG Laser

Background: The use of laser irradiation for dental surface treatment may increase tooth-composite bond strength. Its use on bleached teeth may decrease the waiting time between bleaching and restorative procedures. Objective: This study aimed to evaluate the bond strength between a composite resin and bovine enamel bleached with 35% hydrogen peroxide and etched with Er:YAG laser. Materials and Methods: Thirty bovine teeth were randomly divided into six groups (n = 5): G1, unbleached and restored 24 h after storage in artificial saliva, etching with 35% phosphoric acid (PA) (control); G2, unbleached and restored 24 h after storage in artificial saliva, etching with Er:YAG laser and 35% PA; G3, bleached and restored immediately afterward, etching with 35% PA; G4, bleached and restored 24 h after bleaching, etching with 35% PA; G5, bleached and restored immediately afterward, etching with Er:YAG and 35% PA laser; G6, bleached and restored 24 h after bleaching, etching with Er:YAG laser and 35% PA. Bond strength was quantitatively evaluated by microtensile test (1.0 mm/min). Data were submitted to statistical analysis using ANOVA and Tukey tests (alpha - 0.05). Results: Bond strength values (MPa) were G1, 26.17 +/- 4.44; G2, 28.87 +/- 3.94; G3, 17.25 +/- 4.58; G4, 21.93 +/- 5.02; G5, 16.69 +/- 2.31; and G6, 29.06 +/- 8.31. There was no statistically significant difference among groups G1, G2, and G6 (p - 0.119), which presented higher bond strength than group G4, followed by groups G3 and G5. Conclusion: Er:YAG irradiation of bleached surfaces may favor bonding procedures when performed 24 h after bleaching.

Effects of Optimal Medical Treatment With or Without Coronary Revascularization on Angina and Subsequent Revascularizations in Patients With Type 2 Diabetes Mellitus and Stable Ischemic Heart Disease

Background-In the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial, an initial strategy of coronary revascularization and optimal medical treatment (REV) compared with an initial optimal medical treatment with the option of subsequent revascularization (MED) did not reduce all-cause mortality or the composite of cardiovascular death, myocardial infarction, and stroke in patients with type 2 diabetes mellitus and stable ischemic heart disease. In the same population, we tested whether the REV strategy was superior to the MED strategy in preventing worsening and new angina and subsequent coronary revascularizations. Methods and Results-Among the 2364 men and women (mean age, 62.4 years) with type 2 diabetes mellitus, documented coronary artery disease, and myocardial ischemia, 1191 were randomized to the MED and 1173 to the REV strategy preselected in the percutaneous coronary intervention (796) and coronary artery bypass graft (377) strata. Compared with the MED strategy, the REV strategy at the 3-year follow-up had a lower rate of worsening angina (8% versus 13%; P < 0.001), new angina (37% versus 51%; P = 0.001), and subsequent coronary revascularizations (18% versus 33%; P < 0.001) and a higher rate of angina-free status (66% versus 58%; P = 0.003). The coronary artery bypass graft stratum patients were at higher risk than those in the percutaneous coronary intervention stratum, and had the greatest benefits from REV. Conclusions-In these patients, the REV strategy reduced the occurrence of worsening angina, new angina, and subsequent coronary revascularizations more than the MED strategy. The symptomatic benefits were observed particularly for high-risk patients.